Fundraising Fox
/Companies
Sign in

Gleam

YC S23

San Francisco, US · Founded 2023 · 4 employees · 5 known investors

Find your way into Gleam

Sign up to see every warm intro you have to Gleam

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Gleam team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.

Also known as Gleam Care, Inc.

AI & Machine LearningBiotechEnterprise SoftwareHealthtechSaaSArtificial IntelligenceHealthcareUnited States of AmericaAmerica / CanadaPartly Remote

Founders & leadership· Y Combinator alumni (S23)

Gleam was founded in 2023 by Oliver Keh.

OKOliver Keh
Oliver KehCEO & FounderFounder and CEO of Gleam, an AI-assisted data entry platform for clinical research sites.
EI
Emeka Itegbe

Investors · 5

Y Combinatorlisted by Y CombinatorSan Francisco · $500K

How we know: the Y Combinator directory · open dataset · 5k.vc investor directory · Not right? Tell us

1984 Ventures Management, LlcreportedSan Francisco · $750K – $1M

How we know: Y Combinator's founder network · Not right? Tell us

Hustle FundreportedSan Carlos · $150K

How we know: Y Combinator's founder network · Not right? Tell us

Liquid VenturesreportedSan Francisco · $250K – $5M

How we know: Y Combinator's founder network · Not right? Tell us

Related companies · 5

Synthio LabsSynthio Labs develops AI-powered synthesis and clinical interpretation systems for pharmaceutical interactions, offering text, voice, and video interfaces designed for healthcare professionals and patients that integrate FDA labels, drug mechanisms, and clinical literature.
Pirouette PharmaPirouette develops OnePush, a fully automatic hidden-needle auto-injector platform paired with drug programs across chronic and rescue care indications. The company is advancing clinical-stage programs in naloxone, epinephrine, promethazine, and methotrexate while scaling U.S. automated manufacturing and securing IP protection through 2045.
FrekilFrekil automates real-world evidence generation for pharmaceutical and healthcare research, using AI agents to build patient cohorts, design studies, and generate statistical analyses from existing clinical data. The platform enables epidemiological workflows across drug safety monitoring, comparative effectiveness, label expansion, and trial feasibility assessments.
Granza BioGranza Bio develops immunotherapy treatments leveraging naturally-occurring attack particles that are released from cytotoxic immune cells to target diseases including cancers, autoimmunity, and infections.
NectomeNectome provides cryogenic preservation of the human body and brain shortly after legal death, aiming to preserve neural structure in sufficient detail that future revival may become theoretically possible. The service targets individuals at end-of-life seeking experimental preservation as a potential pathway to future recovery.

Companies working in the same space as Gleam.

Legal entities · 1

corporate structure
Gleam Care, Inc.

Frequently asked questions

What does Gleam do?
Gleam is an AI-assisted data entry tool designed for clinical research sites to move data from source systems into electronic data capture systems faster and with higher accuracy. The product helps clinical research coordinators reduce manual transcription work while maintaining full traceability and coordinator control over data entries.
Who founded Gleam?
Gleam was founded by Oliver Keh in 2023.
Who are Gleam's investors?
Gleam's investors include Focal Ventures, Y Combinator, 1984 Ventures Management, Llc, Hustle Fund, Liquid Ventures.
Where is Gleam headquartered?
Gleam is headquartered in San Francisco, US.